Dr. Samuel A Barritt

Sam was a Ph.D. graduate student in the BBS program at Harvard Medical School and a member of the Dibble Lab from 2018-2022. He was an author on three publications from the lab including a first author Article in Nature and a first author Review in Nature Metabolism. Sam is now a Scientist at ARTBIO in Cambridge, MA.

Barritt SA, DuBois-Coyne SE, Dibble CC. Coenzyme A biosynthesis: mechanisms of regulation, function and disease. Nat Metab. 2024 Jun;6(6):1008-1023.

Crawford MC, Tripu DR, Barritt SA, Jing Y, Gallimore D, Kales SC, Bhanu NV, Xiong Y, Fang Y, Butler KAT, LeClair CA, Coussens NP, Simeonov A, Garcia BA, Dibble CC, Meier JL. Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors. ACS Chem Biol. 2023 Oct 20;18(10):2249-2258.

Dibble CC, Barritt SA*, Perry GE, Lien EC, Geck RC, DuBois-Coyne SE, Bartee D, Zengeya TT, Cohen EB, Yuan M, Hopkins BD, Meier JL, Clohessy JG, Asara JM, Cantley LC, Toker A. PI3K drives the de novo synthesis of coenzyme A from vitamin B5. Nature. 2022 Aug;608(7921):192-198. *co-first author